These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29457853)

  • 21. Schwann cells in pancreatic cancer: Unraveling their multifaceted roles in tumorigenesis and neural interactions.
    Cai Z; Yao H; Chen J; Ahmed AA; Li C; Hu X; Tang X; Jiang C
    Cancer Lett; 2024 Apr; 587():216689. PubMed ID: 38367898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma.
    Li J; Kang R; Tang D
    Cancer Commun (Lond); 2021 Aug; 41(8):642-660. PubMed ID: 34264020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3/TrkC signaling pathway.
    Xu X; Lu X; Chen L; Peng K; Ji F
    J Clin Lab Anal; 2022 Nov; 36(11):e24719. PubMed ID: 36181286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer.
    Zhang W; He R; Yang W; Zhang Y; Yuan Q; Wang J; Liu Y; Chen S; Zhang S; Zhang W; Zhu Z; Zhang J; Wang Z; Li J
    J Exp Clin Cancer Res; 2022 Feb; 41(1):48. PubMed ID: 35109895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aquaporins in pancreatic ductal adenocarcinoma.
    Bruun-Sørensen AS; Edamana S; Login FH; Borgquist S; Nejsum LN
    APMIS; 2021 Dec; 129(12):700-705. PubMed ID: 34582595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma.
    Sánchez-Ramírez D; Medrano-Guzmán R; Candanedo-González F; De Anda-González J; García-Rios LE; Pérez-Koldenkova V; Gutiérrez-de la Barrera M; Rodríguez-Enríquez S; Velasco-Velázquez M; Pacheco-Velázquez SC; Piña-Sánchez P; Mayani H; Gómez-Delgado A; Monroy-García A; Martínez-Lara AK; Montesinos JJ
    Eur J Histochem; 2022 Feb; 66(1):. PubMed ID: 35174683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.
    Shichi Y; Sasaki N; Michishita M; Hasegawa F; Matsuda Y; Arai T; Gomi F; Aida J; Takubo K; Toyoda M; Yoshimura H; Takahashi K; Ishiwata T
    Sci Rep; 2019 Jul; 9(1):10871. PubMed ID: 31350453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas.
    Argon A; Öz Ö; Kebat TA
    Indian J Pathol Microbiol; 2023; 66(1):38-43. PubMed ID: 36656208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated fibroblasts drive early pancreatic cancer cell invasion via the SOX4/MMP11 signalling axis.
    Ge F; Zeng C; Wang J; Liu X; Zheng C; Zhang H; Yang L; Yang B; Zhu H; He Q
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166852. PubMed ID: 37633471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer.
    Göhrig A; Hilfenhaus G; Rosseck F; Welzel M; Moser B; Barbone G; Kunze CA; Rein J; Wilken G; Böhmig M; Malinka T; Tacke F; Bahra M; Detjen KM; Fischer C
    J Exp Clin Cancer Res; 2024 May; 43(1):153. PubMed ID: 38816706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity.
    Schmidtlein PM; Volz C; Braun R; Thürling I; Lapshyna O; Wellner UF; Konukiewitz B; Lehnert H; Marquardt JU; Ungefroren H
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling.
    Alrawashdeh W; Jones R; Dumartin L; Radon TP; Cutillas PR; Feakins RM; Dmitrovic B; Demir IE; Ceyhan GO; Crnogorac-Jurcevic T
    Mol Oncol; 2019 May; 13(5):1075-1091. PubMed ID: 30690892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.
    Mahadevan KK; Arora KS; Amzallag A; Williams E; Kulkarni AS; Fernandez-Del Castillo C; Lillemoe KD; Bardeesy N; Hong TS; Ferrone CR; Ting DT; Deshpande V
    Mod Pathol; 2019 Jun; 32(6):844-854. PubMed ID: 30683911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L1CAM induces perineural invasion of pancreas cancer cells by upregulation of metalloproteinase expression.
    Na'ara S; Amit M; Gil Z
    Oncogene; 2019 Jan; 38(4):596-608. PubMed ID: 30171263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer.
    Taniuchi K; Furihata M; Naganuma S; Saibara T
    Int J Oncol; 2018 Nov; 53(5):2224-2240. PubMed ID: 30226582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis.
    Masuda T; Fukuda A; Yamakawa G; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Nagao M; Araki O; Yoshikawa T; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Masui T; Hatano E; Matsuzaki T; Noda M; Seno H
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37712427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic evaluation of pancreatic ductal adenocarcinoma: Associations between molecular biomarkers and CT imaging findings.
    Noda Y; Goshima S; Tsuji Y; Tomita H; Hara A; Kawaguchi M; Kawada H; Kawai N; Tanahashi Y; Matsuo M
    Pancreatology; 2019 Mar; 19(2):331-339. PubMed ID: 30718187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic Schwann cell reprogramming supports cancer-associated neuronal remodeling.
    Rangel-Sosa MM; Mann F; Chauvet S
    Glia; 2024 Oct; 72(10):1840-1861. PubMed ID: 38961612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models.
    Li D; Yang M; Liang M; Mei C; Lin Y; Yang F; Xiao Y; Chen Y; Wang F; Mao J; Su Z
    Biomater Sci; 2021 Oct; 9(20):6737-6752. PubMed ID: 34254599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia.
    Weitz J; Garg B; Martsinkovskiy A; Patel S; Tiriac H; Lowy AM
    Oncogene; 2023 Aug; 42(34):2536-2546. PubMed ID: 37433986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.